Skip to main content
Caplight Logo









Strike Pharma

Strike Pharma

Private
LundHealthcare & Life Scienceshttps://strikepharma.com

Last Round

Grant

Jul 4, 2024

Total Funding Raised

$5.99M

Company Overview

Strike Pharma operates in Healthcare & Life Sciences and is based in Lund. Its latest recorded funding round was a Grant round in July 2024.

Strike Pharma is a biotechnology company that develops in vivo CAR-T therapies for autoimmune disease and cancer using a proprietary technology for targeted nanoparticle delivery.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Strike Pharma Comparables

Compare Strike Pharma with similar companies based on industry and business-model similarity.

Strike Pharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nouscom
84%
Corner Therapeutics
83%
Geneos Therapeutics
83%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Strike Pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJul 4, 2024
SeedFeb 22, 2022
SeedJun 18, 2021
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Sara Mangsbo

Chief Scientific Officer, Co-Founder

Founding Team

Per Norlén

Chief Executive Officer

Executive Team

Tina Furebring

COO

Executive Team

For institutional investors. Book with your work email.

Strike Pharma Investors

Notable investors and investment history

Strike Pharma investors
InvestorRounds
Flerie InvestSeed
European Regional Development FundGrant
Almi Invest ABSeed
Eir VenturesSeed
Uppsala University InvestSeed
Flerie ABSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 22, 2022

    $4.8M round led by Eir Ventures.

Book a demo to see all signals

For institutional investors. Book with your work email.

Strike Pharma Filings

Explore SEC and related filing metadata, where available.

Strike Pharma filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Strike Pharma's valuation, stock price, and market status.

Is Strike Pharma a public or private company?

Strike Pharma is a private company.

What is the current stock price of Strike Pharma?

Strike Pharma is a private company, so its shares have no public market price. Caplight tracks Strike Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Strike Pharma worth (valuation)?

Valuation information for Strike Pharma is not publicly available.

Can I buy Strike Pharma stock?

Strike Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Strike Pharma's last funding round?

Strike Pharma's most recent funding round was Grant on July 4, 2024.

Who are the main investors in Strike Pharma?

Key investors in Strike Pharma include Eir Ventures.

Will Strike Pharma IPO soon?

No public IPO plans have been announced for Strike Pharma.

How can I track Strike Pharma secondary market activity?

Caplight tracks bids, offers, and trades in Strike Pharma's shares on secondary markets.

Firmographic Details

HeadquartersLund
Employee Range20
Year Founded2020
Last FundingJul 4, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?